While dosing is the most significant determinant, other psychological and pharmacological factors also play a critical role. A positive mood before drug intake was strongly linked to elevated ratings ...

Researchers are investigating whether the drug could be used in mainstream medicine—with and without its hallucinatory ...

This article was originally published on Psychedelic Spotlight and appears here with permission. New study suggests that a non-hallucinogenic LSD analog may hold therapeutic potential for mood ...

Better moods, higher concentration levels, more creativity - and all without the usual risks associated with hard drugs: Proponents of microdosing LSD - taking tiny fractions of the amount needed for ...

A new study published in the journal Neuropsychopharmacology has reported the results of the first modern clinical investigation to compare the acute effects of psychedelics LSD and psilocybin. The ...

Data to Support MindMed's Project Lucy in Preparing Phase 2b Trial for Anxiety Disorders NEW YORK, Nov. 2, 2020 /PRNewswire/ -- MindMed (NEO: MMED, OTCQB: MMEDF), the leading psychedelic medicine ...

Depression is a highly prevalent mental health condition. Because many patients fail to respond to standard therapies, there is a pressing need for alternative approaches. Recently, administration of ...

Benjamin holds a Master's degree in anthropology from University College London and has previously worked in the fields of psychedelic neuroscience and mental health. Benjamin holds a Master's degree ...

The magical and potent hallucinogen lysergic acid diethylamide (LSD) may have a new, clinically significant medical benefit: getting sleep. A new study, entitled “LSD Increases Sleep Duration the ...

Drugs such as magic mushrooms and LSD can act as powerful antidepressants. But they have other impacts, too - mind-bending side effects, for one. NPR's Jon Hamilton reports on a drug based on LSD that ...

Source: By IndependentOo, Dominik from Germany, Maximilian IV, Laitche, NASA; composite artwork by Belbury - CC BY 4.0, Wikimedia Working in his lab at the pharmaceutical company Sandoz in 1938, ...

Data to Support MindMed's Project Lucy in Preparing Phase 2b Trial for Anxiety Disorders Specifically, the Phase 1 study measured LSD dose-dependently induced subjective responses starting at ...